Related Experiment Video
Updated: Jan 21, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials
Laura M Yee1, Lisa M McShane, Boris Freidlin
1From the Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
Abstract:
Oncology clinical trials are undergoing transformation to evaluate targeted therapies addressing a wider variety of biologically defined cancer subgroups. Multiarm basket and umbrella trials conducted under master protocols have become more prominent mechanisms for the clinical evaluation of promising new biologically driven anticancer therapies that are integral to precision oncology medicine. These new trial designs permit efficient clinical evaluation of multiple therapies in a variety of histologically and biologically defined cancers. These complex trials require extensive planning and attention to many factors, including choice of biomarker assay platform, mechanism for processing clinicopathologic and biomarker data to assign patients to substudies, and statistical design, monitoring, and analysis of substudies. Trial teams have expanded to include expertise in the interface between biology, clinical oncology, bioinformatics, and statistics. Strategies for the design, conduct, and analysis of these complex trials will continue to evolve to meet new challenges and opportunities in precision oncology medicine.
Insights
Precision oncology medicine utilizes complex clinical trial designs like multiarm basket and umbrella trials to efficiently evaluate targeted cancer therapies. These innovative approaches require integrated expertise for successful planning, execution, and analysis.
Area of Science:
- Oncology
- Clinical Trial Design
- Precision Medicine
Background:
- Oncology clinical trials are evolving to assess targeted therapies for diverse, biologically defined cancer subgroups.
- Master protocols, including multiarm basket and umbrella trials, are increasingly used for evaluating novel anticancer agents.
Purpose of the Study:
- To highlight the prominence and efficiency of multiarm basket and umbrella trials in precision oncology.
- To discuss the complexities and necessary considerations for designing and conducting these advanced trial structures.
Main Methods:
- Utilizing master protocols to facilitate the evaluation of multiple therapies across various cancer types.
- Integrating biomarker assay platforms and robust data processing for patient stratification into substudies.
- Emphasizing the need for statistical design, monitoring, and analysis tailored to complex substudy structures.
Main Results:
- These trial designs enable efficient evaluation of targeted therapies in biologically defined cancer populations.
- Successful implementation requires multidisciplinary teams with expertise in biology, clinical oncology, bioinformatics, and statistics.
Conclusions:
- Multiarm basket and umbrella trials are essential for advancing precision oncology medicine.
- Continued evolution of strategies for design, conduct, and analysis is crucial to address future challenges and opportunities in targeted cancer therapy evaluation.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Biostatistics: Overview
Discrete variables are...
Overview of Biostatistics in Health Sciences
Design Consideration
The factor of safety is another key...

